Your browser doesn't support javascript.
loading
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.
Ishiyama, K; Kitawaki, T; Sugimoto, N; Sozu, T; Anzai, N; Okada, M; Nohgawa, M; Hatanaka, K; Arima, N; Ishikawa, T; Tabata, S; Onaka, T; Oka, S; Nakabo, Y; Amakawa, R; Matsui, M; Moriguchi, T; Takaori-Kondo, A; Kadowaki, N.
Afiliación
  • Ishiyama K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kitawaki T; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sugimoto N; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Sozu T; Department of Clinical Application, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Anzai N; Department of Management Science, Faculty of Engineering, Tokyo University of Science, Tokyo, Japan.
  • Okada M; Department of Hematology and Oncology, Takatsuki Red Cross Hospital, Takatsuki, Japan.
  • Nohgawa M; Department of Hematology and Oncology, Takatsuki Red Cross Hospital, Takatsuki, Japan.
  • Hatanaka K; Department of Hematology, Wakayama Red Cross Hospital, Wakayama, Japan.
  • Arima N; Department of Hematology, Wakayama Red Cross Hospital, Wakayama, Japan.
  • Ishikawa T; Department of Hematology, Kitano Hospital, Osaka, Japan.
  • Tabata S; Department of Hematology, Kobe City Medical Center, Kobe, Japan.
  • Onaka T; Department of Hematology, Kobe City Medical Center, Kobe, Japan.
  • Oka S; Department of Hematology, Kokura Memorial Hospital, Kitakyusyu, Japan.
  • Nakabo Y; Department of Hematology and Oncology, Shiga Medical Center for Adults, Moriyama, Japan.
  • Amakawa R; The Center for Hematological Diseases, Takeda General Hospital, Kyoto, Japan.
  • Matsui M; Department of Hematology, The Japan Baptist Hospital, Kyoto, Japan.
  • Moriguchi T; Department of Hematology, Kyoto City Hospital, Kyoto, Japan.
  • Takaori-Kondo A; Department of Hematology, Kyoto-Katsura Hospital, Kyoto, Japan.
  • Kadowaki N; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Leukemia ; 31(1): 203-212, 2017 01.
Article en En | MEDLINE | ID: mdl-27349810
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Leucemia Mielógena Crónica BCR-ABL Positiva / Citomegalovirus / Análisis de Componente Principal / Dasatinib Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Leucemia Mielógena Crónica BCR-ABL Positiva / Citomegalovirus / Análisis de Componente Principal / Dasatinib Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Japón